| Serial Number | 98201386 |
| Word Mark | ASKFIRST |
| Filing Date | Thursday, September 28, 2023 |
| Status | 686 - PUBLISHED FOR OPPOSITION |
| Status Date | Friday, November 21, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, January 28, 2025 |
| Goods and Services | Promoting collaboration between scientists, technicians, clinical specialists, patients, and their families to achieve advances in therapeutics, technology, regulatory requirements, and public policy in the field of healthcare, genetic disease, gene therapy, and clinical trials |
| Goods and Services | Providing patient advocate services in the field of genetic disease, gene therapy, and potential curative therapies; providing personal support services for patients, namely, emotional counseling and emotional support by providing personal emotional support information in the fields of genetic disease, gene therapy, and potential curative therapies; providing patient advocacy and personal emotional support services to potential participants and participants in clinical trials for genetic diseases and gene therapy; providing information in the field of personal emotional support of gene therapy patients and patients' families |
| Pseudo Mark | ASK FIRST |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 11, 2023 |
| Primary Code | 035 |
| First Use Anywhere Date | Sunday, June 14, 2020 |
| First Use In Commerce Date | Sunday, June 14, 2020 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 11, 2023 |
| Primary Code | 045 |
| First Use Anywhere Date | Sunday, June 14, 2020 |
| First Use In Commerce Date | Sunday, June 14, 2020 |
| Party Name | Asklepios BioPharmaceutical, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Research Triangle Park, NC 27709 |
| Party Name | Asklepios BioPharmaceutical, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Research Triangle Park, NC 27709 |
| Event Date | Event Description |
| Monday, October 2, 2023 | NEW APPLICATION ENTERED |
| Wednesday, October 11, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, February 2, 2024 | ASSIGNED TO EXAMINER |
| Thursday, February 8, 2024 | NON-FINAL ACTION WRITTEN |
| Thursday, February 8, 2024 | NON-FINAL ACTION E-MAILED |
| Thursday, February 8, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, May 8, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, May 8, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, May 8, 2024 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, May 8, 2024 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, May 8, 2024 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Wednesday, May 8, 2024 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Wednesday, May 8, 2024 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Thursday, August 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, November 4, 2024 | ASSIGNED TO LIE |
| Monday, November 4, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, November 4, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, December 9, 2024 | FINAL REFUSAL WRITTEN |
| Monday, December 9, 2024 | FINAL REFUSAL E-MAILED |
| Monday, December 9, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, January 7, 2025 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, January 7, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, January 7, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 8, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, January 22, 2025 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, January 28, 2025 | PUBLISHED FOR OPPOSITION |
| Tuesday, January 28, 2025 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, March 25, 2025 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Monday, April 14, 2025 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Wednesday, October 1, 2025 | TEAS POST PUBLICATION AMENDMENT RECEIVED |
| Friday, November 21, 2025 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
| Wednesday, October 1, 2025 | NOTICE OF ALLOWANCE CANCELLED |
| Friday, November 21, 2025 | 1(B) BASIS DELETED; PROCEED TO REGISTRATION |